-

Robbins LLP: SHAREHOLDER REMINDER: QuantumScape Corporation (QS) is Being Sued for Misleading Shareholders

SAN DIEGO & SAN JOSE, Calif.--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP reminds investors that a purchaser of QuantumScape Corporation (NYSE: QS) filed a class action complaint against the Company and its officers and directors for alleged violations of the Securities Exchange Act of 1934 between November 27, 2020 and December 31, 2020. QuantumScape develops battery technology for electric vehicles and other applications.

If you suffered a loss due to QuantumScape Corporation's misconduct, click here.

QuantumScape Corporation (QS) Misled Shareholders by Overstating the Viability, Power and Life of its Solid-State Battery

According to the complaint, on November 27, 2020, QuantumScape went public via a business combination with Kensington Capital Acquisition Corp. A joint press release issued by QuantumScape and Kensington, characterized QuantumScape as "a leader in the development of next generation solid-state lithium-metal batteries for use in electric vehicles." Throughout the relevant period, QuantumScape touted the success of its battery technology.

On January 4, 2021, Seeking Alpha published an article pointing to several risks with QuantumScape's solid-state batteries that make it "completely unacceptable for real world field electric vehicles." The article stated that the battery's power "will only last for 260 cycles or about 75,000 miles of aggressive driving." As solid-state batteries are temperature sensitive, "the power and cycle tests at 30 and 45 degrees above would have been significantly worse if run even a few degrees lower." The article further detailed significant challenges QuantumScape faces. On this new, QuantumScape's stock plummeted $34.49, or over 40%, to close at $49.96 per share on January 4, 2021.

If you purchased shares of QuantumScape Corporation (QS) between November 27, 2020 and December 31, 2020, you have until March 8, 2021, to ask the court to appoint you lead plaintiff for the class.

Contact us to learn more:
Lauren Levi
(800) 350-6003
llevi@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against QuantumScape settles or to receive free alerts about companies engaged in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Lauren Levi
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Stockholder Notice: Robbins LLP Informs Investors of the Super Micro Computer, Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Super Micro Computer, Inc. (NASDAQ: SMCI) securities between April 30, 2024 and March 19, 2026. Super Micro is a technology company that designs, develops, and manufactures high-performance server and storage systems, primarily for artificial intelligence (“AI”), data center, and cloud solutions customers. For more information, submit a form,...

BlackRock TCP Capital Corp. Investor Alert - TCPC Stockholders with Large Losses Should Contact Robbins LLP for Information About the Securities Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired BlackRock TCP Capital Corp. (NASDAQ: TCPC) securities between November 6, 2024 and January 23, 2026. BlackRock TCP is a business development company that raises funds from investors and then uses those funds to make loans to small and midsize businesses as an alternative to bank financing. For more information, submit a form, email attorney Aa...

MREO Investor Alert - Mereo BioPharma Group plc Investors with Large Losses Should Contact Robbins LLP for Information About the Securities Fraud Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Mereo BioPharma Group plc. (NASDAQ: MREO) American Depository Shares ("ADS") between June 5, 2023 and December 26, 2025. Mereo is a biopharmaceutical company focused on the development of therapeutics for rare diseases. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. What are the alleg...
Back to Newsroom